Schedule 13G ownership disclosure

Amphastar Pharmaceuticals Inc

Security class unavailable · CUSIP: 03209R103

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,037,158
Percent of class
12.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001086364-24-001477
Form type
SC 13G/A
Filer
Amphastar Pharmaceuticals, Inc.
CIK
CIK 1297184
Filed
Jan 23, 2024
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub